From the results of in vitro tests, cefpiramide (CPM, SM-1652) was shown to be active against patient's strains of at least 2 species, S. aureus and P. aeruginosa. Twelve patients of respiratory tract infections were treated with 2 g a day of cefpiramide. Clinical responses were excellent in 6 cases, good in 4 and poor in 2. As for side effects, exanthema, discomfort of the chest and discomfort of the lower extremities were observed in 1 case each. Elevation of transaminases was seen in 4 cases.
|出版ステータス||Published - 1983 1 1|
ASJC Scopus subject areas
- Pharmacology (medical)
- Infectious Diseases
- Drug Discovery